Rubicon Research Limited Q2 FY26 results deck summary

NSE: RUBICON · BSE: 544578

Results deck of 13 Nov 2025, summarised by AI from the filing.

Q2 FY26 revenue ₹4,120 mn, up 39.2% YoY, with EBITDA margin at 22.9% and gross margin down to 68.7% on higher outsourcing.

Q2 revenue Revenue from operations ₹4,120 mn in Q2 FY26, up 39.2% YoY from ₹2,960 mn.
EBITDA margin EBITDA margin expected to sustain at current levels even as gross margin trends towards 68%.
Growth driver Broad-based revenue growth with top 10 products at 51% of revenue vs 56% in Q1 FY26.
Capacity risk Own manufacturing capacity constraint in select dosage forms increased outsourced manufacturing until Pithampur ramps up.

Rubicon Research Limited Q1 FY27 results

As filed: Revenue ₹428 cr, EBITDA ₹125 cr, PAT ₹82.5 cr, EBITDA margin 29.2%.

Not scored. No result for the same quarter last year.

Q4 FY26: Revenue ₹514 cr, EBITDA ₹119 cr, PAT ₹76.8 cr, EBITDA margin 23.1%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹514 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +40.9% in 27 days (Nifty 500: +2.0%).
Q3 FY26: Revenue ₹476 cr, EBITDA ₹108 cr, PAT ₹72.8 cr, EBITDA margin 22.7%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹476 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +4.1% in 30 days (Nifty 500: −3.2%).
Q2 FY26: Revenue ₹336 cr, EBITDA ₹79.0 cr, PAT ₹46.0 cr, EBITDA margin 23.5%. Not scored. No result for the same quarter last year. Share price after the results: −2.8% in 29 days (Nifty 500: −0.4%).

Past price moves after results do not indicate future moves. Not a recommendation.

Figures from the company's filings with NSE and BSE. Not investment advice.